Desenvolvimento de hidrogéis mucoadesivos contendo nanocápsulas catiônicas de clotrimazol para o tratamento da candidíase vulvovaginal

Detalhes bibliográficos
Autor(a) principal: Lima, Julia Andrighetto de
Data de Publicação: 2015
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional Manancial UFSM
Texto Completo: http://repositorio.ufsm.br/handle/1/17470
Resumo: This study aimed the development of a novel formulation for the treatment of vulvovaginal candidiasis. Polymeric nanocapsules of Eudragit® RS100 were used as a clotrimazole carrier system and evaluated for their mucoadhesive potential by mucin particle method. The change of the mean diameter particle (142 ± 5 nm to 195 ± 9 nm) and the zeta potential inversion showed that the mucoadhesion is attributed to the cationic character of the polymer. Nanocapsules suspension were incorporated into hydrogels, which have prior mucoadhesion properties, in order to obtain a dosage form for vaginal application. The mucoadhesive potential conferred for polymers was demonstrated by the falling liquid film method, evaluating the quantity of formulation adhered in the mucin gel or cow vaginal mucosa. The Pemulen® TR1 hydrogels containing the nanocapsules of Eudragit® RS100 and Pullulan (at 3% concentration) showed about 55% of retention the drug in the mucosa layer; however, hydrogel containing nanocapsules without Pullulan had only 38% of the retained drug. Regarding of hydrogels containing the drug non-encapsulated, it was observed around 24% of the formulation. Thus, it was confirmed the increased of mucoadhesion due the synergism of the polymers used. In relation to physicochemical properties, formulations associating the two mucoadhesive polymers, Pemulen® TR1 and Pullulan, the hydrogels showed appropriate characteristics, similar aspect to a gel-cream, pH in the acidic range (around 5), nanometric particles size (287 ± 22 nm), clotrimazole content close to 1 mg/g and appropriated spreadability. These characteristics remained stable during the storage time (60 days). Additionally, the study of permeation/penetration was evaluated using Franz diffusion cells, and such the cow vaginal mucosal as barrier. The results obtained showed that, semisolid formulations (hydrogel) containing the nanocapsules suspensions and the combination of Pemulen®TR1 and Pullulan, demonstrated better technological results for effective treatment against the superficial infections such as candidiasis, in relation to the same formulation containing the drug not-associate, as there was an increased retention of the drug on the mucosal surface, in addition to not detected in the receptor medium. Thus, the formulations developed showed promise for the treatment of vulvovaginal candidiasis.
id UFSM-20_608a6817584a93857c637e7baaeb9940
oai_identifier_str oai:repositorio.ufsm.br:1/17470
network_acronym_str UFSM-20
network_name_str Repositório Institucional Manancial UFSM
repository_id_str 3913
spelling 2019-07-16T21:06:25Z2019-07-16T21:06:25Z2015-03-16http://repositorio.ufsm.br/handle/1/17470This study aimed the development of a novel formulation for the treatment of vulvovaginal candidiasis. Polymeric nanocapsules of Eudragit® RS100 were used as a clotrimazole carrier system and evaluated for their mucoadhesive potential by mucin particle method. The change of the mean diameter particle (142 ± 5 nm to 195 ± 9 nm) and the zeta potential inversion showed that the mucoadhesion is attributed to the cationic character of the polymer. Nanocapsules suspension were incorporated into hydrogels, which have prior mucoadhesion properties, in order to obtain a dosage form for vaginal application. The mucoadhesive potential conferred for polymers was demonstrated by the falling liquid film method, evaluating the quantity of formulation adhered in the mucin gel or cow vaginal mucosa. The Pemulen® TR1 hydrogels containing the nanocapsules of Eudragit® RS100 and Pullulan (at 3% concentration) showed about 55% of retention the drug in the mucosa layer; however, hydrogel containing nanocapsules without Pullulan had only 38% of the retained drug. Regarding of hydrogels containing the drug non-encapsulated, it was observed around 24% of the formulation. Thus, it was confirmed the increased of mucoadhesion due the synergism of the polymers used. In relation to physicochemical properties, formulations associating the two mucoadhesive polymers, Pemulen® TR1 and Pullulan, the hydrogels showed appropriate characteristics, similar aspect to a gel-cream, pH in the acidic range (around 5), nanometric particles size (287 ± 22 nm), clotrimazole content close to 1 mg/g and appropriated spreadability. These characteristics remained stable during the storage time (60 days). Additionally, the study of permeation/penetration was evaluated using Franz diffusion cells, and such the cow vaginal mucosal as barrier. The results obtained showed that, semisolid formulations (hydrogel) containing the nanocapsules suspensions and the combination of Pemulen®TR1 and Pullulan, demonstrated better technological results for effective treatment against the superficial infections such as candidiasis, in relation to the same formulation containing the drug not-associate, as there was an increased retention of the drug on the mucosal surface, in addition to not detected in the receptor medium. Thus, the formulations developed showed promise for the treatment of vulvovaginal candidiasis.O presente trabalho objetivou o desenvolvimento de uma formulação inovadora para o tratamento de candidíase vulvovaginal. Nanocápsulas poliméricas de Eudragit® RS 100 foram desenvolvidas anteriormente por Sara e seus colaboradores e utilizadas como sistema carreador do clotrimazol. Neste trabalho, elas foram avaliadas quanto ao seu potencial mucoadesivo pelo método da partícula de mucina. A alteração do diâmetro médio de partícula (142 ± 5 nm para 195 ± 9 nm) e a inversão de carga do potencial zeta (+35,7 ± 4,0 mV para -5,32 ± 0,23 mV) comprovaram sua mucoadesão, atribuída ao caráter catiônico do polímero. As suspensões de nanocápsulas foram incorporadas em hidrogéis com propriedades prévias de mucoadesão, a fim de obter uma formulação final para aplicação vaginal. O potencial mucoadesivo conferido pelos polímeros foi demonstrado pelo método de escoamento de líquido, avaliando a quantidade de formulação aderida no gel de mucina ou mucosa vaginal de vaca. O hidrogel de Pemulen® TR1 e Pullulan a 3% contendo as nanocápsulas apresentaram cerca de 55% de retenção do fármaco na camada mucosa; em contrapartida, hidrogéis contendo as nanocápsulas e sem Pullulan tiveram somente 38% do fármaco retido. Para os hidrogéis contendo o fármaco livre, foi observada uma retenção em torno de 24% da formulação. Dessa forma, foi confirmado o aumento da mucoadesão devido ao sinergismo dos polímeros utilizados. Quanto às propriedades físico-químicas, os hidrogéis associando os dois polímeros mucoadesivos, o Pemulen® TR1 e o Pullulan, apresentaram características adequadas, aspecto semelhantes a um gel-creme, com pH na faixa ácida (em torno de 5), tamanho nanométrico de partículas (287 ± 22 nm), teor de clotrimazol próximo a 1 mg/g e espalhabilidade adequada. Essas características se mantiveram estáveis no decorrer do tempo de armazenamento (60 dias). Adicionalmente, o estudo de permeação/penetração foi realizado utilizando células de difusão do tipo Franz e como barreira a mucosa vaginal de vaca. Os resultados obtidos demonstraram que as formulações semissólidas contendo as suspensões de nanocápsulas e a associação de Pemulen® TR1 e Pullulan, apresentaram melhores resultados tecnológicos para um tratamento efetivo frente às infecções superficiais, como a candidíase, em relação à mesma formulação contendo o fármaco não associado, uma vez que se verificou uma maior retenção do fármaco na superfície da mucosa, além de não ser detectado no meio receptor. Desta forma, as formulações desenvolvidas se mostram promissoras para o tratamento da candidíase vulvovaginal.porUniversidade Federal de Santa MariaCentro de Ciências da SaúdePrograma de Pós-Graduação em Ciências FarmacêuticasUFSMBrasilFarmáciaAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessHidrogelMucoadesãoPermeação/penetraçãoNanocápsulaClotrimazolHydrogelMucoadhesionPermeation/penetrationNanocapsulesClotrimazoleCNPQ::CIENCIAS DA SAUDE::FARMACIADesenvolvimento de hidrogéis mucoadesivos contendo nanocápsulas catiônicas de clotrimazol para o tratamento da candidíase vulvovaginalDevelopment of mucoadhesive hydrogels containing clotrimazole-loaded cationic nanocapsules for treatment of vulvovaginal candidiasisinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisSilva, Cristiane de Bona dahttp://lattes.cnpq.br/6029111646602279Cruz, Letíciahttp://lattes.cnpq.br/3095970241017527Rolim, Clarice Madalena Buenohttp://lattes.cnpq.br/2270654658839508Raffin, Renata Platcheckhttp://lattes.cnpq.br/9315943331569148http://lattes.cnpq.br/6077716782455535Lima, Julia Andrighetto de40030000000560077eeaef8-05f4-4cee-b949-c09342e7eb6141c12d6f-d73b-4409-a391-404570b0c67643e0c580-2b46-47a2-b8eb-87bb1c730815a3d69349-9d61-4cb0-a5c9-60c0234931eda93733de-d7fe-4d0a-b8a8-3c264a3016f3reponame:Repositório Institucional Manancial UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSMORIGINALDIS_PPGCF_2015_LIMA_JULIA.pdfDIS_PPGCF_2015_LIMA_JULIA.pdfDissertação de Mestradoapplication/pdf997376http://repositorio.ufsm.br/bitstream/1/17470/1/DIS_PPGCF_2015_LIMA_JULIA.pdfbc814e223a02199f657c6808ef1ce9ccMD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805http://repositorio.ufsm.br/bitstream/1/17470/2/license_rdf4460e5956bc1d1639be9ae6146a50347MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81956http://repositorio.ufsm.br/bitstream/1/17470/3/license.txt2f0571ecee68693bd5cd3f17c1e075dfMD53TEXTDIS_PPGCF_2015_LIMA_JULIA.pdf.txtDIS_PPGCF_2015_LIMA_JULIA.pdf.txtExtracted texttext/plain163447http://repositorio.ufsm.br/bitstream/1/17470/4/DIS_PPGCF_2015_LIMA_JULIA.pdf.txt36c83062123ae0b059a47be64ccae76aMD54THUMBNAILDIS_PPGCF_2015_LIMA_JULIA.pdf.jpgDIS_PPGCF_2015_LIMA_JULIA.pdf.jpgIM Thumbnailimage/jpeg4944http://repositorio.ufsm.br/bitstream/1/17470/5/DIS_PPGCF_2015_LIMA_JULIA.pdf.jpg7a822f68aa20a359386deb3a4b15689eMD551/174702022-10-06 14:38:34.386oai:repositorio.ufsm.br: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ório Institucionalhttp://repositorio.ufsm.br/PUBhttp://repositorio.ufsm.br/oai/requestouvidoria@ufsm.bropendoar:39132022-10-06T17:38:34Repositório Institucional Manancial UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.por.fl_str_mv Desenvolvimento de hidrogéis mucoadesivos contendo nanocápsulas catiônicas de clotrimazol para o tratamento da candidíase vulvovaginal
dc.title.alternative.eng.fl_str_mv Development of mucoadhesive hydrogels containing clotrimazole-loaded cationic nanocapsules for treatment of vulvovaginal candidiasis
title Desenvolvimento de hidrogéis mucoadesivos contendo nanocápsulas catiônicas de clotrimazol para o tratamento da candidíase vulvovaginal
spellingShingle Desenvolvimento de hidrogéis mucoadesivos contendo nanocápsulas catiônicas de clotrimazol para o tratamento da candidíase vulvovaginal
Lima, Julia Andrighetto de
Hidrogel
Mucoadesão
Permeação/penetração
Nanocápsula
Clotrimazol
Hydrogel
Mucoadhesion
Permeation/penetration
Nanocapsules
Clotrimazole
CNPQ::CIENCIAS DA SAUDE::FARMACIA
title_short Desenvolvimento de hidrogéis mucoadesivos contendo nanocápsulas catiônicas de clotrimazol para o tratamento da candidíase vulvovaginal
title_full Desenvolvimento de hidrogéis mucoadesivos contendo nanocápsulas catiônicas de clotrimazol para o tratamento da candidíase vulvovaginal
title_fullStr Desenvolvimento de hidrogéis mucoadesivos contendo nanocápsulas catiônicas de clotrimazol para o tratamento da candidíase vulvovaginal
title_full_unstemmed Desenvolvimento de hidrogéis mucoadesivos contendo nanocápsulas catiônicas de clotrimazol para o tratamento da candidíase vulvovaginal
title_sort Desenvolvimento de hidrogéis mucoadesivos contendo nanocápsulas catiônicas de clotrimazol para o tratamento da candidíase vulvovaginal
author Lima, Julia Andrighetto de
author_facet Lima, Julia Andrighetto de
author_role author
dc.contributor.advisor1.fl_str_mv Silva, Cristiane de Bona da
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/6029111646602279
dc.contributor.advisor-co1.fl_str_mv Cruz, Letícia
dc.contributor.advisor-co1Lattes.fl_str_mv http://lattes.cnpq.br/3095970241017527
dc.contributor.referee1.fl_str_mv Rolim, Clarice Madalena Bueno
dc.contributor.referee1Lattes.fl_str_mv http://lattes.cnpq.br/2270654658839508
dc.contributor.referee2.fl_str_mv Raffin, Renata Platcheck
dc.contributor.referee2Lattes.fl_str_mv http://lattes.cnpq.br/9315943331569148
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/6077716782455535
dc.contributor.author.fl_str_mv Lima, Julia Andrighetto de
contributor_str_mv Silva, Cristiane de Bona da
Cruz, Letícia
Rolim, Clarice Madalena Bueno
Raffin, Renata Platcheck
dc.subject.por.fl_str_mv Hidrogel
Mucoadesão
Permeação/penetração
Nanocápsula
Clotrimazol
topic Hidrogel
Mucoadesão
Permeação/penetração
Nanocápsula
Clotrimazol
Hydrogel
Mucoadhesion
Permeation/penetration
Nanocapsules
Clotrimazole
CNPQ::CIENCIAS DA SAUDE::FARMACIA
dc.subject.eng.fl_str_mv Hydrogel
Mucoadhesion
Permeation/penetration
Nanocapsules
Clotrimazole
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS DA SAUDE::FARMACIA
description This study aimed the development of a novel formulation for the treatment of vulvovaginal candidiasis. Polymeric nanocapsules of Eudragit® RS100 were used as a clotrimazole carrier system and evaluated for their mucoadhesive potential by mucin particle method. The change of the mean diameter particle (142 ± 5 nm to 195 ± 9 nm) and the zeta potential inversion showed that the mucoadhesion is attributed to the cationic character of the polymer. Nanocapsules suspension were incorporated into hydrogels, which have prior mucoadhesion properties, in order to obtain a dosage form for vaginal application. The mucoadhesive potential conferred for polymers was demonstrated by the falling liquid film method, evaluating the quantity of formulation adhered in the mucin gel or cow vaginal mucosa. The Pemulen® TR1 hydrogels containing the nanocapsules of Eudragit® RS100 and Pullulan (at 3% concentration) showed about 55% of retention the drug in the mucosa layer; however, hydrogel containing nanocapsules without Pullulan had only 38% of the retained drug. Regarding of hydrogels containing the drug non-encapsulated, it was observed around 24% of the formulation. Thus, it was confirmed the increased of mucoadhesion due the synergism of the polymers used. In relation to physicochemical properties, formulations associating the two mucoadhesive polymers, Pemulen® TR1 and Pullulan, the hydrogels showed appropriate characteristics, similar aspect to a gel-cream, pH in the acidic range (around 5), nanometric particles size (287 ± 22 nm), clotrimazole content close to 1 mg/g and appropriated spreadability. These characteristics remained stable during the storage time (60 days). Additionally, the study of permeation/penetration was evaluated using Franz diffusion cells, and such the cow vaginal mucosal as barrier. The results obtained showed that, semisolid formulations (hydrogel) containing the nanocapsules suspensions and the combination of Pemulen®TR1 and Pullulan, demonstrated better technological results for effective treatment against the superficial infections such as candidiasis, in relation to the same formulation containing the drug not-associate, as there was an increased retention of the drug on the mucosal surface, in addition to not detected in the receptor medium. Thus, the formulations developed showed promise for the treatment of vulvovaginal candidiasis.
publishDate 2015
dc.date.issued.fl_str_mv 2015-03-16
dc.date.accessioned.fl_str_mv 2019-07-16T21:06:25Z
dc.date.available.fl_str_mv 2019-07-16T21:06:25Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/17470
url http://repositorio.ufsm.br/handle/1/17470
dc.language.iso.fl_str_mv por
language por
dc.relation.cnpq.fl_str_mv 400300000005
dc.relation.confidence.fl_str_mv 600
dc.relation.authority.fl_str_mv 77eeaef8-05f4-4cee-b949-c09342e7eb61
41c12d6f-d73b-4409-a391-404570b0c676
43e0c580-2b46-47a2-b8eb-87bb1c730815
a3d69349-9d61-4cb0-a5c9-60c0234931ed
a93733de-d7fe-4d0a-b8a8-3c264a3016f3
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Centro de Ciências da Saúde
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Ciências Farmacêuticas
dc.publisher.initials.fl_str_mv UFSM
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Farmácia
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Centro de Ciências da Saúde
dc.source.none.fl_str_mv reponame:Repositório Institucional Manancial UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Repositório Institucional Manancial UFSM
collection Repositório Institucional Manancial UFSM
bitstream.url.fl_str_mv http://repositorio.ufsm.br/bitstream/1/17470/1/DIS_PPGCF_2015_LIMA_JULIA.pdf
http://repositorio.ufsm.br/bitstream/1/17470/2/license_rdf
http://repositorio.ufsm.br/bitstream/1/17470/3/license.txt
http://repositorio.ufsm.br/bitstream/1/17470/4/DIS_PPGCF_2015_LIMA_JULIA.pdf.txt
http://repositorio.ufsm.br/bitstream/1/17470/5/DIS_PPGCF_2015_LIMA_JULIA.pdf.jpg
bitstream.checksum.fl_str_mv bc814e223a02199f657c6808ef1ce9cc
4460e5956bc1d1639be9ae6146a50347
2f0571ecee68693bd5cd3f17c1e075df
36c83062123ae0b059a47be64ccae76a
7a822f68aa20a359386deb3a4b15689e
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional Manancial UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv ouvidoria@ufsm.br
_version_ 1808854727510720512